Refine Search

  •  
  •  
'99 Merck study a ploy, doctors say

...reliever, naproxen, when it published results indicating Vioxx was better tolerated. Dr. Jonathan Edelman, the head of scientific affairs at Merck Research Laboratories, said Monday "the ADVANTAGE study was primarily a scientific study" designed...

http://chronicle.augusta.com/stories/2008/08/19/bus_469932.shtml
Business
Scientists agonized over choosing less-than-perfect flu vaccine

...the time you know what's the right strain, you can't do anything about it," said Dr. Michael Decker, head of scientific affairs at Aventis, one of the three U.S. vaccine makers. The first inkling of something worrisome dawned on flu...

http://chronicle.augusta.com/stories/2003/12/16/liv_392085.shtml
Life & style
1